Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Treatment Annual Report for 2007. Data on the prognosis of 3381 patients with cervical cancer, 3681 with endometrial cancer, and 2367 with ovarian cancer for whom treatment was initiated in 2007 were analyzed in the Treatment Annual Report. In the 2007 Treatment Annual Report, stage I accounted for 53.1%, stage II for 24.4%, stage III for 14.2%, and stage IV for 8.3% of all patients with cervical cancer. Stage I accounted for 64.8%, stage II for 8.2%, stage III for 20.2%, and stage IV for 6.9% of all patients with endometrial cancer. Stage I accounted for 41.4%, stage II for 9.9%, stage III for 30.6%, and stage IV for 8.6% of all patients with ovarian cancer. The 5-year overall survival rates for patients with cervical cancer were 91.8% for stage I, 71.5% for stage II, 53.0% for stage III, and 23.7% for stage IV; those for patients with endometrial cancer were 95.3%, 89.8%, 75.6%, and 29.1%, and those for patients with ovarian surface epithelial-stromal tumors were 91.5%, 76.1%, 46.9%, and 31.3%, respectively.

Original languageEnglish
JournalJournal of Obstetrics and Gynaecology Research
DOIs
Publication statusAccepted/In press - 2015

Fingerprint

Annual Reports
Gynecology
Obstetrics
Japan
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Therapeutics
Neoplasms
Survival Rate

Keywords

  • Annual report
  • Cervical cancer
  • Endometrial cancer
  • Gynecologic cancers
  • Japan
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

@article{004fe46b71774fb8acd642b703247110,
title = "Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology",
abstract = "The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Treatment Annual Report for 2007. Data on the prognosis of 3381 patients with cervical cancer, 3681 with endometrial cancer, and 2367 with ovarian cancer for whom treatment was initiated in 2007 were analyzed in the Treatment Annual Report. In the 2007 Treatment Annual Report, stage I accounted for 53.1{\%}, stage II for 24.4{\%}, stage III for 14.2{\%}, and stage IV for 8.3{\%} of all patients with cervical cancer. Stage I accounted for 64.8{\%}, stage II for 8.2{\%}, stage III for 20.2{\%}, and stage IV for 6.9{\%} of all patients with endometrial cancer. Stage I accounted for 41.4{\%}, stage II for 9.9{\%}, stage III for 30.6{\%}, and stage IV for 8.6{\%} of all patients with ovarian cancer. The 5-year overall survival rates for patients with cervical cancer were 91.8{\%} for stage I, 71.5{\%} for stage II, 53.0{\%} for stage III, and 23.7{\%} for stage IV; those for patients with endometrial cancer were 95.3{\%}, 89.8{\%}, 75.6{\%}, and 29.1{\%}, and those for patients with ovarian surface epithelial-stromal tumors were 91.5{\%}, 76.1{\%}, 46.9{\%}, and 31.3{\%}, respectively.",
keywords = "Annual report, Cervical cancer, Endometrial cancer, Gynecologic cancers, Japan, Ovarian cancer",
author = "Wataru Yamagami and Daisuke Aoki",
year = "2015",
doi = "10.1111/jog.12833",
language = "English",
journal = "Asia-Oceania Journal of Obstetrics and Gynaecology",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",

}

TY - JOUR

T1 - Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology

AU - Yamagami, Wataru

AU - Aoki, Daisuke

PY - 2015

Y1 - 2015

N2 - The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Treatment Annual Report for 2007. Data on the prognosis of 3381 patients with cervical cancer, 3681 with endometrial cancer, and 2367 with ovarian cancer for whom treatment was initiated in 2007 were analyzed in the Treatment Annual Report. In the 2007 Treatment Annual Report, stage I accounted for 53.1%, stage II for 24.4%, stage III for 14.2%, and stage IV for 8.3% of all patients with cervical cancer. Stage I accounted for 64.8%, stage II for 8.2%, stage III for 20.2%, and stage IV for 6.9% of all patients with endometrial cancer. Stage I accounted for 41.4%, stage II for 9.9%, stage III for 30.6%, and stage IV for 8.6% of all patients with ovarian cancer. The 5-year overall survival rates for patients with cervical cancer were 91.8% for stage I, 71.5% for stage II, 53.0% for stage III, and 23.7% for stage IV; those for patients with endometrial cancer were 95.3%, 89.8%, 75.6%, and 29.1%, and those for patients with ovarian surface epithelial-stromal tumors were 91.5%, 76.1%, 46.9%, and 31.3%, respectively.

AB - The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Treatment Annual Report for 2007. Data on the prognosis of 3381 patients with cervical cancer, 3681 with endometrial cancer, and 2367 with ovarian cancer for whom treatment was initiated in 2007 were analyzed in the Treatment Annual Report. In the 2007 Treatment Annual Report, stage I accounted for 53.1%, stage II for 24.4%, stage III for 14.2%, and stage IV for 8.3% of all patients with cervical cancer. Stage I accounted for 64.8%, stage II for 8.2%, stage III for 20.2%, and stage IV for 6.9% of all patients with endometrial cancer. Stage I accounted for 41.4%, stage II for 9.9%, stage III for 30.6%, and stage IV for 8.6% of all patients with ovarian cancer. The 5-year overall survival rates for patients with cervical cancer were 91.8% for stage I, 71.5% for stage II, 53.0% for stage III, and 23.7% for stage IV; those for patients with endometrial cancer were 95.3%, 89.8%, 75.6%, and 29.1%, and those for patients with ovarian surface epithelial-stromal tumors were 91.5%, 76.1%, 46.9%, and 31.3%, respectively.

KW - Annual report

KW - Cervical cancer

KW - Endometrial cancer

KW - Gynecologic cancers

KW - Japan

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84946559263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946559263&partnerID=8YFLogxK

U2 - 10.1111/jog.12833

DO - 10.1111/jog.12833

M3 - Article

C2 - 26420746

AN - SCOPUS:84946559263

JO - Asia-Oceania Journal of Obstetrics and Gynaecology

JF - Asia-Oceania Journal of Obstetrics and Gynaecology

SN - 1341-8076

ER -